Key result
Elevated NT-proBNP links to increased cardiovascular event risk and serves as a diagnostic screening tool.
NT-proBNP is a stable biomarker of cardiac function that can be measured via immunoassay to identify individuals at risk for cardiovascular events such as atrial fibrillation and stroke.
No immediate screening change warranted; leaves open prospective validation of NT-proBNP utility.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Arun Kumar (2023) conducted a review in Atrial Fibrillation and Stroke. NT-proBNP screening was evaluated. Elevated levels of NT-proBNP are associated with an increased risk of cardiovascular events, such as atrial fibrillation and stroke, and can be used as a diagnostic screening tool.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: